View in EDS

The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.

Saved in:
Bibliographic Details
Title: The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.
Authors: Ianni E; GSK, Siena, Italy. Electronic address: elvira.x.ianni@gsk.com., Stranges D; GSK, Siena, Italy., O'Hagan DT; GSK, Cambridge, MA, United States.
Source: Current opinion in virology [Curr Opin Virol] 2026 Jul 10; Vol. 77, pp. 101568. Date of Electronic Publication: 2026 Jul 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101560941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-6265 (Electronic) Linking ISSN: 18796257 NLM ISO Abbreviation: Curr Opin Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42430984
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ianni+E%22">Ianni E</searchLink>; GSK, Siena, Italy. Electronic address: elvira.x.ianni@gsk.com.<br /><searchLink fieldCode="AU" term="%22Stranges+D%22">Stranges D</searchLink>; GSK, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22O'Hagan+DT%22">O'Hagan DT</searchLink>; GSK, Cambridge, MA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560941%22">Current opinion in virology</searchLink> [Curr Opin Virol] 2026 Jul 10; Vol. 77, pp. 101568. <i>Date of Electronic Publication: </i>2026 Jul 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101560941 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-6265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218796257%22">18796257 </searchLink><i>NLM ISO Abbreviation: </i>Curr Opin Virol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42430984
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.coviro.2026.101568
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101568
    Titles:
      – TitleFull: The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ianni E
      – PersonEntity:
          Name:
            NameFull: Stranges D
      – PersonEntity:
          Name:
            NameFull: O'Hagan DT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2026 Jul 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-6265
          Numbering:
            – Type: volume
              Value: 77
          Titles:
            – TitleFull: Current opinion in virology
              Type: main
ResultId 1